Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 28Gynecologic 4Thoracic 3Genitourinary 3Gastrointestinal 3Dermatologic 3Sarcoma 2Plasma cell 1Other hematologic neoplasm 1Head & Neck 1

Conditions

Sarcoma 16Osteosarcoma 10Carcinosarcoma 9Neoplasm Metastasis 8Rhabdomyosarcoma 7Neuroblastoma 7Melanoma 6Lymphoma, Non-Hodgkin 6Endometrial Neoplasms 6Wilms Tumor 5Sarcoma, Ewing 5Rhabdoid Tumor 5Ovarian Neoplasms 5Lung Neoplasms 5Liposarcoma 5Leiomyosarcoma 5Histiocytosis, Langerhans-Cell 5Hepatoblastoma 5Gliosarcoma 5Glioblastoma 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Non-Small-Cell Lung 5Carcinoma, Hepatocellular 5Sarcoma, Kaposi 4Neuroectodermal Tumors, Primitive, Peripheral 4Medulloblastoma 4Histiocytoma, Malignant Fibrous 4Glioma 4Ependymoma 4

Interventions

pembrolizumab 7Cyclophosphamide 6Nivolumab 4fludarabine 3spartalizumab 2aldesleukin 2Trastuzumab 2Standard of Care 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Irinotecan 2Ipilimumab 2Gemcitabine 2zanidatamab 1vocimagene amiretrorepvec 1veliparib 1tucatinib 1trilaciclib 1trebananib 1trastuzumab duocarmazine 1toripalimab 1tislelizumab 1tinostamustine 1talazoparib 1sarilumab 1sargramostim 1regorafenib 1pexidartinib 1pertuzumab 1pegfilgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Triple Negative Breast Neoplasms × Specimen Handling × Sarcoma × Clear all
NCT04514484 2026-05-28

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

National Cancer Institute (NCI)

Phase 1 Active not recruiting
8 enrolled 32 charts
BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Kaposi, HIV Infections, Carcinoma, Medullary, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT05269381 2026-03-12

PNeoVCA

Mayo Clinic

Phase 1/2 Recruiting
132 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡